3rd Circ. Doubts Merck's Arbitration Bid In Vaccine Suit
The Third Circuit appeared skeptical of Merck Sharp & Dohme Corp.'s bid for more time to build its case for keeping antitrust claims over vaccine prices out of court, suggesting Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article